Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors. Read more about Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Read more about Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.
High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Read more about High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.
Could a coffee a day keep the inflammasome away? Read more about Could a coffee a day keep the inflammasome away?
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Read more about Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas.
Macrophages build a wall and the host pays for it. Read more about Macrophages build a wall and the host pays for it.
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Read more about Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Read more about Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
Stiff discipline for cells in pulmonary hypertension. Read more about Stiff discipline for cells in pulmonary hypertension.
